Drug Profile
Midazolam oral spray - Arovella Therapeutics
Alternative Names: NVD-301; SUDA-003Latest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator NovaDel Pharma
- Developer Arovella Therapeutics
- Class Antiepileptic drugs; Benzodiazepines; Chlorinated hydrocarbons; Fluorobenzenes; Hypnosedatives; Imidazoles; Sleep disorder therapies; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anxiety disorders